Quoin Pharmaceuticals Stock Jumps 38%

Shares of Quoin Pharmaceuticals, Ltd. (QNRX) are surging nearly 38% on Tuesday morning despite no stock-relate news to drive the shares.

QNRX is currently trading at $5.63, up $1.55 or 37.99%, on the Nasdaq, on a volume of 2.9 million shares, above average volume of 0.2 million. The stock opened its trading at $6.78 after closing Monday's trading at $4.08.

The stock has been trading down for the past one-month period, in which it lost nearly 50%. The stock is still down nearly 80% in the year-to-date period.

Quoin Pharmaceuticals is a specialty pharmaceutical company that focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Pharma Stocks by Subscribing to RTT Biotech Investor.
Follow RTT